SCHEMBL6092785

SCHEMBL6092785

O=C(Nc1ccc(NCCN2CCCC2)nc1)c1c[nH]c2c1C(=O)CCC2

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KIT P10721 1/20 0.41
TMEM97 Q5BJF2 1/20 0.38
SIGMAR1 Q99720 1/20 0.38
BUB1 O43683 6/20 0.37
MAP3K11 Q16584 1/20 0.36
ROCK2 O75116 1/20 0.36
ROCK1 Q13464 1/20 0.36
HRH3 Q9Y5N1 1/20 0.36
NMT1 P30419 1/20 0.35
TERT O14746 1/20 0.35
PIM1 P11309 1/20 0.34
FLT3 P36888 1/20 0.34
PIM3 Q86V86 1/20 0.34
BRSK1 Q8TDC3 1/20 0.34
AURKB Q96GD4 1/20 0.34
MKNK2 Q9HBH9 1/20 0.34
KDM4E B2RXH2 1/20 0.34
MEN1 O00255 1/20 0.34
USP2 O75604 1/20 0.34
ALDH1A1 P00352 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6092145 0.93 LCK (0.40) HPGDKCNH2
SCHEMBL6092075 0.87 HCAR3 (0.40) BUB1ROCK2ROCK1MEN1ALDH1A1
SCHEMBL6093483 0.85 HCAR3 (0.43) KITBUB1ROCK2ROCK1KDM4E
SCHEMBL6095310 0.85 HCAR3 (0.42) ROCK2ROCK1FLT3ALDH1A1MAPT
SCHEMBL6093288 0.85 ROCK2 (0.39) BUB1ROCK2ROCK1MEN1ALDH1A1
SCHEMBL6095908 0.82 HCAR3 (0.41) BUB1ROCK2ROCK1MEN1ALDH1A1
SCHEMBL6093985 0.82 ROCK2 (0.35) BUB1ROCK2ROCK1PIM1MEN1
SCHEMBL6394774 0.81 ROCK2 (0.42) BUB1ROCK2ROCK1MEN1ALDH1A1
SCHEMBL6093234 0.81 KMT2A (0.46) KITBUB1ROCK2ROCK1KDM4E
SCHEMBL6095397 0.80 HRH3 (0.46) HRH3FLT3MAPTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7109351-B1 Fused pyrrolecarboxamides; GABA brain receptor ligands NEUROGEN CORPORATION (US) 2006-09-19 US disclosed
US-20050014939-A1 Fused pyrrolecarboxamides: GABA brain receptor ligands NEUROGEN CORPORATION 2005-01-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050014939-A1 Fused pyrrolecarboxamides: GABA brain receptor ligands GABRB2, GABRB1, GABRB3 KIT 2319/4885TMEM97 109/4885SIGMAR1 133/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.